eCommons@AKU
Section of Cardiology

Department of Medicine

8-28-2020

Pericardiocentesis indications and complications: A retrospective
observational study in a tertiary care hospital in Karachi, Pakistan
Abdul Baqi
Intisar Ahmed

Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_med_cardiol
Part of the Cardiology Commons

Open Access Original
Article

DOI: 10.7759/cureus.10102

Pericardiocentesis Indications and
Complications: A Retrospective
Observational Study in a Tertiary Care
Hospital in Karachi, Pakistan
Abdul Baqi 1 , Intisar Ahmed 2
1. Cardiology, Aga Khan University Hospital, Karachi, PAK 2. Cardiology, Aga Khan University Hospital,
Karachi, PAK
Corresponding author: Abdul Baqi, dr_abkhana@yahoo.com

Abstract
Introduction: Pericardiocentesis is crucial for the diagnosis and management of diseases
responsible for significant pericardial effusions. Pericardiocentesis was performed the first time
by Riolanus for cardiac tamponade. He described the process of trephination of the sternum to
remove the abnormally accumulated fluid from the pericardial space. However, with the
advancement of expertise in echocardiography assisted procedures, echocardiography-guided
diagnostic and therapeutic pericardiocentesis is now considered standard clinical practice in
the treatment of pericardial effusions.
Objectives: We aim to study different causes of pericardial effusion and indications of
pericardiocentesis as well as complications associated with it in our population.
Methods: This is a retrospective observational study done at Aga Khan University Hospital,
Karachi. We reviewed hospital record files of 66 patients admitted to Aga Khan University
Hospital from January 2010 to December 2019 who underwent pericardiocentesis.
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Results: Out of 66 patients, 43 (65.2%) were male. The mean age of the study population was
48.59±18.9 years and 41 (62.1%) of them had underlying active malignancy with hematological
malignancies being most common followed by lung carcinoma. In the majority of patients
(71.2%), pericardiocentesis was performed at the bedside, and the rest of them (28.8%)
underwent pericardiocentesis in the cardiac catheterization laboratory. Of all the patients, 46
(69.7%) underwent pericardiocentesis under echocardiography guidance and 18 (27.3%)
required fluoroscopy. Successful pericardiocentesis was performed in 65 (98.5%) of the
patients, two (3%) patients developed access site infection and only one (1.5%) patient became
hemodynamically unstable while undergoing pericardiocentesis
Conclusion: Malignancy, predominantly lymphoma, is the most common cause of pericardial
effusion requiring pericardiocentesis. Dyspnea is the most common symptom of presentation
with cardiac tamponade. Echocardiography is the commonly used imaging modality for
pericardiocentesis. Bedside setting is the most common setting used for pericardiocentesis.
Imaging guided pericardiocentesis has a very high success and low complication rate.
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Introduction
Pericardiocentesis is crucial for the diagnosis and management of diseases responsible for
significant pericardial effusions. Pericardiocentesis was performed the first time by Riolanus for
cardiac tamponade. He described the process of trephination of the sternum to remove the
abnormally accumulated fluid from the pericardial space [1]. Blind pericardiocentesis without
any imaging assistance was used in the past, but that failed to gain wide support due to high
morbidity, life-threatening complications more than 20%, and mortality approaching 6% [2].
However, with the advancement of expertise in echocardiography assisted procedures in the
1970s, pericardiocentesis became crucial for the diagnosis and management of diseases
responsible for significant pericardial effusions. Echocardiography-guided pericardiocentesis
both diagnostic and therapeutic at this time is considered the ideal clinical practice for the
management of pericardial effusions [3].
Pericardiocentesis can be done without harm in hemodynamically stable patients in an
outpatient setting. Pericardiocentesis can be performed quickly by an expert cardiologist in
hemodynamically unstable patients to relieve symptoms of cardiac tamponade [4]. In medium
to large-sized pericardial effusions, echocardiography-assisted pericardiocentesis has high
success rates of >95% with very little risk. The morbidity rate is approximately 1-3% and the
mortality rate associated directly with the procedure is less than 1% [5].
In 2005, Khan et al. described the clinical and echocardiographic features of Pakistani patients
with pericardial effusion requiring pericardiocentesis and reported a success rate of around 93%
for echocardiographic pericardiocentesis [6]. Since then, there is no data on procedural success
and complications of pericardiocentesis in our population. We aim to study the causes of
pericardial effusion, indications of pericardiocentesis in our population as well as
complications associated with it, as this will help us understand procedural success and
complications of the procedure in the contemporary era of advanced techniques.

Materials And Methods
Study population
This is a retrospective observational study done at Aga Khan University Hospital, Karachi,
which is a multidisciplinary tertiary care hospital with a cardiology and cardiac surgery center
that is one of the main referral health facilities in Pakistan.
This study was approved by Aga Khan University ethical review committee (ERC No. 20192253-5880). We reviewed hospital record files of consecutive 66 patients, admitted to Aga Khan
University Hospital from January 2010 to December 2019, who underwent pericardiocentesis.
For all patients, demographic information including age, gender, and symptoms on
presentation was recorded after reviewing written medical records. Comorbidities were
tabulated including diabetes mellitus, hypertension, coronary artery disease, congestive heart
failure, cardiomyopathy, and valvular heart disease. Echocardiographic data were reviewed for
the size of pericardial effusion, distribution of pericardial effusion, echocardiographic signs of
tamponade, and left ventricular systolic function. The size of the pericardial effusion was
graded as small (<10 mm), medium (10-20 mm), and large (20 mm) on bases of largest echofree space, when viewed from the transthoracic echocardiographic window. Etiology of
pericardial effusion was established based on clinical reasoning, lab reports, echocardiography
report, and the results of the pericardial fluid analysis.

Procedure
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After informed consent, pericardiocentesis was performed by a trained cardiologist under
standard aseptic measures. Details of procedure including access site, anesthesia, imaging
modality, and complications were recorded. Procedure success was defined as successful
drainage pericardial fluids with the placement of a pericardial drain if required.

In-hospital monitoring
All patients were followed from the time of the procedure to the time of discharge or death.
Hemodynamic parameters including heart rate and blood pressure were recorded at the time of
procedure and post-procedure till the time of discharge. Complications related to
pericardiocentesis were recorded.

Statistical analysis
All statistical analyses were performed using the Statistical Package for Social Sciences (SPSS)
version 23 (IBM Corp., Armonk, NY). Continuous variables were expressed as mean value ±
standard deviation and categorical variables were expressed as frequencies and percentages.

Results
Baseline characteristics
Out of 66 patients, 43 (65.2%) were male, and the mean age of the study population was
48.59±18.9 years. Hypertension and diabetes mellitus was found in 36 (54.5%) and 25 (27.2%)
patients, respectively. Coronary artery disease, chronic kidney disease, and chronic obstructive
pulmonary disease were found in four (6.1%), six (9.1%), and three (4.5%) of the patients,
respectively. Out of 66 patients, 41 (62.1%) of them had underlying active malignancy with
hematological malignancies being most common followed by lung carcinoma (Table 1).
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Variable

No. (%)

Age, mean (SD) year

48.59±18.9

Sex
Male

43 (65.2)

Female

23(34.8)

Active cancer

41(62.1)

Hypertension

36 (54.5)

Diabetes Mellitus

25(27.2)

Ischemic heart disease

4(6.1)

Congestive heart failure

7(10.6)

Chronic kidney disease

6(9.1)

COPD

3(4.5)

TABLE 1: Patients demographics and baseline characteristics (n = 66)
COPD: chronic obstructive pulmonary disease

Presenting symptoms and echocardiographic features
The majority of patients (63, 95.5%) presented with shortness of breath, and only three of them
presented with hypotension (Table 2). Echocardiogram revealed large pericardial effusion in 61
(92.6%) patients, medium-sized effusion in five (7.4%) patients and all of them had
echocardiographic features of tamponade including early diastolic right atrial and end-diastolic
right ventricular collapse, abnormal respiratory variation in tricuspid and mitral flow velocities,
dilated inferior vena cava with lack of inspiratory collapse. The mean left ventricular ejection
fraction of the study population was 53.18±7.7% (Table 3).

Symptoms

No (%)

Dyspnea

63(95.5)

Hypotension

3(4.5)

TABLE 2: Presenting symptoms.
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Variable

No (%)

Left ventricular ejection fraction mean (SD)

53.18+7.72

Size of pericardial effusion
Large

61(92.4)

Medium

5(7.6)

Tamponade physiology
Yes

66(100)

No

0

Distribution of pericardial effusion
Circumferential

66(100)

Loculated

0(0)

TABLE 3: Echocardiographic characteristics.

Cause of pericardial effusion and indication of
pericardiocentesis
In 41 (62.1%) patients, malignancy was the cause of pericardial effusion followed by viral
pericarditis, tuberculous pericarditis, and uremic pericarditis in four (6.1%) patients each.
Connective tissue disorders, hypothyroidism, and right heart failure were the cause of
pericardial effusion in three (4.5%), two (3.0%), and two (3.0%) patients, respectively. One
(1.5%) patient developed pericardial effusion due to post-myocardial infarction pericarditis
(Table 4). Half of the patients underwent pericardiocentesis for therapeutic and the rest of them
underwent diagnostic as well as therapeutic purposes.
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Etiology

No (%)

Active cancer

41(62.1)

Lung

12(18.2)

Leukemia/lymphoma

16(24.2)

Breast

3(4.5)

Gastrointestinal

2(3.0)

Head and neck

2(2.0)

Thymoma

2(3.0)

Thyroid gland

1(1.5)

Gynecological

1(1.5)

Genitourinary

1(1.5)

Viral pericarditis

4(6.1)

Tuberculous pericarditis

4(6.1)

Uremic pericarditis

4(6.1)

Post MI pericarditis

1(1.5)

Connective tissue disorders

3(4.5)

Hypothyroidism

2(3.0)

Right heart failure

2(3.0)

Post CABG

1(1.5)

Others

4(6.1)

TABLE 4: Etiology of cardiac tamponade.
CABG: coronary artery bypass grafting

Procedure and procedure-related complications
In the majority of patients (47, 71.2%), pericardiocentesis was performed at the bedside and in
the rest (19, 28.8%) pericardiocentesis was performed at the cardiac catheterization laboratory.
Of all the patients, 46 (69.7%) underwent pericardiocentesis under echocardiography guidance
and 18 (27.3%) required echocardiography for localization and fluoroscopy for confirmation of
effusion. Two of the patients underwent the blind procedure without imaging guidance due to
the life-threatening condition of the patient and the non-availability of echocardiography
machine at the bedside during the procedure (Table 5).
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Variable

No (%)

Setting of Pericardiocentesis
Bedside

47(71.2)

Cath lab

19(28.8)

Conscious sedation

65(98.5)

General anesthesia

1(1.5)

Guided
Echo

46(69.7)

Echo and Fluoroscopy

18(27.3)

Blind without imaging

2(3.0)

Site of entry
Subcostal

66(100)

Apical

0(0)

Catheter used
Pigtail

61(92.4)

Sheath

5(7.6)

TABLE 5: Procedural details.

In the majority of patients, pericardiocentesis was performed under local anesthesia via a
subcostal approach and a pigtail catheter was inserted in pericardial space. Successful
pericardiocentesis was performed in 65 (98.5%) of the patients, two (3%) patients developed
access site infection and only one (1.5%) patient became hemodynamically unstable while
undergoing pericardiocentesis due to relative hypovolemia associated with underlying infection
(Table 6).

variables

No (%)

Infection

2(3.0)

Hemodynamic derangement

1(1.5)

TABLE 6: Complications of pericardiocentesis.

Out of those patients who underwent successful pericardiocentesis, 25 (38.4%) required
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pericardiac window due to recurrent pericardial effusion caused by malignancy. None of the
patients died due to the procedure or procedure-related complications.

Discussion
This is the largest hospital-based study on pericardiocentesis from Pakistan to the best of our
knowledge. This study demonstrates that all patients had tamponade physiology at the time of
pericardiocentesis, malignancy predominantly lymphoma is the most common cause of
pericardial effusion, dyspnea is the most common symptom of cardiac tamponade, and
echocardiogram is the most commonly used imaging modality for pericardiocentesis and
procedure success is very high with low peri-procedure complications.
Malignancies, predominantly lymphomas, are the most common cause of pericardial effusion in
our study population followed by lung carcinoma. This finding is consistent with local and
international data. In the study by Khan et al., malignancy was the cause of pericardial effusion
in more than 50% of the patients [6]. In another study from Saudi Arabia, in 48.7% of the
patients, malignancy was the cause of the pericardial effusion [7]. Malignancies and uremia
were reported to be the most common cause in the western population [8,9], while Turank et al.
reported that the most common cause of pericardial effusion is idiopathic [10]. The mean age of
our study population was 48.9 years as compared to 52.1 years in the study from Saudi Arabia
[7].
Dyspnea was the most common presenting symptom in our study population followed by
hypotension. In the study by Khan et al., 89% of the patients with pericardial effusion presented
with dyspnea [6]. Sagristà-Sauleda et al. reported dyspnea as a presenting symptom in 83% of
the patients followed by pleuritic chest pain in 42% of the patients [11]. The presence of
inflammatory signs or symptoms, e.g. fever and pleuritic chest, may help to differentiate the
different causes of pericardial effusion. Agner et al. observed that absence of inflammatory
symptoms, large pericardial effusion, cardiomegaly, and pleural effusion was associated with
malignant or tuberculous pericardial effusion [12]. In our study population, the majority of
patients had large pericardial effusion and all of them had echocardiographic evidence of
cardiac tamponade.
In the majority of the patients, pericardiocentesis was performed under echocardiographic
guidance and less than one-third underwent fluoroscopy-guided pericardiocentesis. Worldwide,
echocardiography is the most commonly use imaging modality for pericardiocentesis and it is
associated with high success rate and low peri-procedure complication [13].
Our study reports a pericardiocentesis success rate of 98.5% with relatively low complications.
However, more than one-third of the patients required a pericardial window due to recurrent
pericardial effusion. These findings are consistent with the literature. Khan et al. reported a
success rate of 95.5% for echocardiography guided pericardiocentesis [6]. Albugami et al.
reported re-accumulation of pericardial effusion as high as 21% [7]. Rate of major
complications including pneumothorax and myocardial perforation under echocardiographic or
fluoroscopy-guided pericardiocentesis is reported to be 0.3 to 3.9% in observational studies
[13,14].
Pericardiocentesis was done via a subcostal or subxiphoid approach in our study population,
which is reported to be associated with a low risk of pneumothorax [15].
Our study is not free of limitations. It is a retrospective observational study and sample size is
small which may not represent the whole Pakistani population. There is no control group, so it
is not possible to establish the association of pericardial effusion with mortality. There is no
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long-term follow-up.

Conclusions
Malignancy, predominantly lymphoma, is the most common cause of pericardial effusion
requiring pericardiocentesis. Dyspnea is the most common symptom of presentation with
cardiac tamponade. Echocardiography is the commonly used imaging modality for
pericardiocentesis. Bedside setting is the most common setting used for pericardiocentesis.
Imaging guided pericardiocentesis has a very high success and low complication rate.
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